Table 2 Epidemiologic and histologic characterizations between low risk EC women with and without recurrences
|  | EC FFPE primary tumor no recurrence, N = 14 | EC FFPE primary tumor recurrences, N = 7 | p-value |
|---|---|---|---|
Age, median (IQR) | 60 (45–82) | 66 (57–76) | 0.45 |
Diabetes n (%) | 1 (7%) | 1 (14%) | 1 |
Dyslipidemia n (%) | 2 (14%) | 1 (14%) | 1 |
Parity, median (IQR) | 2 (0–5) | 2 (1–4) | 0.93 |
BMI, median (IQR) | 28 (18–39) | 26 (23–36) | 0.60 |
Histologic grade, n (%) | Â | Â | 1 |
 Grade 1 | 12 (85%) | 6 (85%) | 0.70 |
 Grade 2 | 2 (15%) | 1 (15%) | |
 Tumor size (mm), median (IQR) | 16 (5–50) | 35 (9–45) | |
Time between surgery and sample analysis (months), median (IQR) | 165 (94–204) | 137 (59–202) | 0.52 |
Vaginal brachytherapy after surgery | 10 (71%) | 2 (28%) | 0.16 |